Edgen Stock·Sep 18 2025, 12:53戻る
Pfizer Advances Vaccine and Pipeline, Bolstering Healthcare Sector Outlook
Edgen Stock·Sep 18 2025, 12:53
[1] Phase 3 Data Supports FDA Approval for Pfizer Inc. (PFE)’s 2025–2026 COVID-19 Vaccine (https://finance.yahoo.com/news/phase-3-data-s ...)[2] Pfizer, Moderna post data backing COVID shots (PFE:NYSE) | Seeking Alpha (https://vertexaisearch.cloud.google.com/groun ...)[3] Pfizer touts positive topline data for RSV vaccine Abrysvo - Clinical Trials Arena (https://vertexaisearch.cloud.google.com/groun ...)
